Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Aster chinensis aerial parts metabolites refer to a complex mixture of natural products extracted from the stalks and flowers of the *Aster chinensis* plant, specifically those cultivated in Egypt. In preclinical research published in 2025, these metabolites—particularly the methylene chloride fraction of the stalks—demonstrated significant anti-psoriatic activity in Imiquimod-induced skin inflammation models. The extract's efficacy is attributed to a diverse profile of bioactive compounds, including flavonoids, terpenoids, phenolics, glycosides, fatty acids, lignans, and sterols, which collectively improve PASI scores, histopathological markers, and the spleen index in animal models.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Aster chinensis aerial parts metabolites.